Low booster uptake in cancer patients despite health benefits.

Jane C FigueiredoJulia LevySo Yung ChoiAlexander M XuNoah M MerinOmid HamidTucker LemosNathalie NguyenMaimoona NadriAlma GonzalezSimeon MahovJustin M DarrahJun GongRonald L PaquetteAlain C MitaRobert A VescioSarah J SalvyInderjit MehmiAndrew E HendifarRonald NataleWarren G TourtellotteV Krishnan RamanujanCarissa A HuynhKimia SobhaniKaren L ReckampAkil A Merchant

Published in: medRxiv : the preprint server for health sciences (2023)

COVID-19 booster vaccinations increase antibody levels and maintain T-cell responses against SARS-CoV-2 in patients receiving various anti-cancer therapiesBooster vaccinations reduced all-cause mortality in patientsA significant proportion of patients remain unboosted and strategies are needed to encourage patients to be up-to-date with vaccinations.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
healthcare
prognostic factors
mental health
risk assessment
patient reported outcomes
social media